Why drug repurposing is so significant for drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Why drug repurposing is so significant for drug discovery” which covers two articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW.

They are called: AI use in repurposing drugs for Covid-19 and RRx-001: Jack of all trades, master of…many.

In the first article, Imran Haque, VP Data Science at Recursion, describes the journey of the AI platform that predicted the efficacy of repurposed drugs for Covid-19

In the second article, Bryan Oronsky, Chief Development Officer at EpicentRx, discusses how one drug sourced from the defense and aerospace industry, could have many potential disese targets.

You can also find The Drug Discovery World Podcast on SpotifyGoogle Play and Apple Podcasts. 

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free